Cannabis Science Inc (fka CBIS)

[Carna4z]

xtremepicks updated letter 8:48 pm Wenessday
Cannabis Science (CBIS) - Momentum is building, something is brewing!Wednesday, March 7, 2012 8:32 PM
From: "[e-mail]" <[e-mail]>Add sender to ContactsTo:

HALL OF FAME! DROP - 83,000% LBSR - 4,500% GTA.v - 1,300% VCTY - 1,500%

Cannabis Science (CBIS) - Momentum is building, something is brewing!


CBIS is on high news watch as we expect the company to continue its press release push that seems to be building towards a monster update. CBIS continues to be very liquid and posting higher highs and higher lows - a solid trading environment for any mega gain potential play.

Read the CBIS research report and see why this is a 500%+ potential gain stock!

Article except: ” It doesn't take a rocket scientist to realize that this industry is growing and that there are untold riches to be made here," said Troy Dayton, the chief executive of the ArcView Group.”

CLICK HERE FOR THE REPORT



CBIS closed at $0.16 posting another daily gain of 6.06% - increasing volumes definitely indicating a breakout pattern to record highs. With news expected, prices can jump fast and furious.

Barcharts indicating strong buy for CBIS

We especially like to see technical indicators supporting a bullish breakout as indicated by barcharts.com. With news, trading action can get super wild, and the potential for some serious gains.




About Cannabis Science, Inc.

Cannabis Science, Inc. is at the forefront of pharmaceutical grade medical marijuana research and development. The second formulations will address the needs of patients choosing to use concentrated cannabis extracts to treat their ailments. Eventually, all Americans will have access to a safe and effective FDA approved medicine regardless of which state they live in. To maintain that marijuana is a dangerous, addictive drug with no medical value is scientifically absurd. Cannabis medicines, with no effective lethal dose, are far safer than aspirin, acetaminophen, and most other OTC drugs that kill thousands of Americans every year.

The Company works with world authorities on phytocannabinoid science targeting critical illnesses, and adheres to scientific methodologies to develop, produce and commercialize phytocannabinoid-based pharmaceutical products. In sum, we are dedicated to the creation of cannabis-based medicines, both with and without psychoactive properties, to treat disease and the symptoms of disease, as well as for general health maintenance.

Keep your eyes peeled for the latest updates on our twitter page, facebook page, and our website at http://www.xtremepicks.com.